Logo
x

Search

Subscribe Now

 osteoporosis

Samsung Bioepis Report the CHMP’s Positive Opinion of Obodence & Xbryk (Biosimilar, Prolia & Xgeva)

Samsung Bioepis Report the CHMP’s Positive Opinion of Obodence & Xbryk (Biosimilar, Prolia & Xgeva)

  • November 15, 2024
Naitive Technologies Join Forces with Parvizi Surgical Innovation to Advance Osteoporosis Detection

Naitive Technologies Join Forces with Parvizi Surgical Innovation to Advance Osteoporosis Detection

  • November 7, 2024
Alvotech Reports the EMA’s Acceptance of MAA for AVT03 (Biosimilar, Prolia and Xgeva)

Alvotech Reports the EMA’s Acceptance of MAA for AVT03 (Biosimilar, Prolia and Xgeva)

  • October 10, 2024
GlycoNex Reports the Completion of P-I Study Assessing SPD8 (Biosimilar, Prolia) for Osteoporosis

GlycoNex Reports the Completion of P-I Study Assessing SPD8 (Biosimilar, Prolia) for Osteoporosis

  • August 16, 2024
Alvotech Reports Data from Confirmatory Trial of AVT03 (Biosimilar, Prolia and Xgeva)

Alvotech Reports Data from Confirmatory Trial of AVT03 (Biosimilar, Prolia and Xgeva)

  • July 3, 2024
Alvotech and STADA Extend their Strategic Partnership Covering AVT03 (Biosimilar, Denosumab)

Alvotech and STADA Extend their Strategic Partnership Covering AVT03 (Biosimilar, Denosumab)

  • June 12, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.